PharmiWeb

BioTesserae Conducts Milestone First in Dog Studies with Proprietary PD-1 Single Domain Antibody

BioTesserae Inc. (BTC), a biotechnology company focused on innovative veterinary therapeutics, in collaboration with Sunflower Therapeutics PBC, a public benefit corporation transforming global access ...
PharmiWeb

ImmuVia Selects Quantori’s Q-Scientist Platform to Accelerate Development of First-in-Class Cancer Therapy

ImmuVia Inc., a biotechnology company developing first-in-class therapies for solid tumors, today announced that it has selected Quantori, a leading provider of digital transformation services and ...
PharmiWeb

VectorBuilder Introduces High-Stability MuteFree™ AAV to Improve Gene Therapy Manufacturing Reliability

VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in ...
PharmiWeb

Infinx Revenue Cycle and Patient Access Platforms Attain HITRUST i1 Certification for Defined Scope

Certification reflects independent assessment and assurance for in-scope platforms and supporting environments CUPERTINO, CA / ACCESS Newswire / April 14, 2026 / Infinx, a provider of AI, automation, ...
PharmiWeb

Debiopharm to Unveil New Pre-Clinical and Clinical Research Advances in DDR Inhibition, Dual Payload ADCs, and AI-Driven Biomarkers at AACR 2026

Preliminary clinical results of the MYTHIC study will be presented, revealing for the first time data of the combination of WEE1 and PKMYT1 inhibition (zedoresertib and lunresertib) for the treatment ...
PharmiWeb

Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements

Further advancements in Europe and the US increase capacity and process efficiencyConstruction of new clinical manufacturing ...
PharmiWeb

Dyve Biosciences and Moffitt Cancer Center Report Promising Study Results for First-of-Its-Kind Topical Therapy Targeting Tumor Acidity

Novel therapy that works throughout the body boosted immune response and slowed tumor growth in early studies, pointing to a potential breakthrough treatment approachCAMARILLO, Calif.--(BUSINESS WIRE) ...
PharmiWeb

Kivu Bioscience Appoints Mohit Trikha, Ph.D., as Chief Executive Officer

Proven oncology leader to advance next-generation ADC pipeline and drive clinical milestonesSAN MATEO, Calif.--(BUSINESS WIRE)--#ADC--Kivu Bioscience, a clinical-stage biotechnology company developing ...
PharmiWeb

CrossBridge Bio Enters an Agreement to be Acquired by Eli Lilly to Advance Next-Generation Dual-Payload Antibody-Drug Conjugates

CrossBridge Bio’s pipeline includes a potential best-in-class TROP2-targeting TOP1i/ATRi dual-payload ADC anticipated to enter the clinic in 2026Acquisition provides an innovative synergistic dual ...
PharmiWeb

U.S. FDA Grants RMAT Designation to GS-100, Grace Science’s Gene Therapy to Treat NGLY1 Deficiency

Grace Science, LLC, a biotechnology company founded to develop novel therapies based on the function of NGLY1, announced today that the U.S. Food and Drug Administration (FDA) has granted Regenerative ...
PharmiWeb

New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

Standard-of-care imaging and risk models indicated cancer after lung screening revealed 30-millimeter pulmonary noduleCyPath® Lung test affirmed physician’s assessment that the nodule could be ...
PharmiWeb

From Photo to Plate in Seconds: Snapshot Recipes Redefines Cooking With AI-Powered Recipe Generation

Users can instantly create meals, desserts, and drinks by typing ideas, uploading photos, or snapping ingredients-powered by a fast, evolving AI platform MESA, AZ / ACCESS Newswire / April 14, 2026 / ...